Skip to main content
Premium Trial:

Request an Annual Quote

A Cloud on the Horizon for Funding?

While the America Competes Act passed by Congress should increase science funding in the US, Wired Science notes that just how much money will be appropriated for that bill will be decided in early 2011. "House Republicans have made the National Science Foundation a symbol of wasteful spending, so America Competes may still lose," writes Wired's Brandon Keim. The reauthorization of the bill calls for $45 billion in funding — including $23.5 billion for NSF, $16.9 billion for the DOE's Office of Science, and $2.9 billion for NIST, among others, as our sister publication GenomeWeb Daily News reported earlier this month. Science advisor John Holdren wrote on the White House blog that "full funding of the Competes Act is among the most important things that Congress can do to ensure America's continued leadership in the decades ahead."

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.